For its second fiscal quarter (ending June 30), Intra-Cellular Therapies Inc (NASDAQ: ITCI) has reported E.P.S. of $-0.16 compared to $-0.45 a year ago. This performance was $0.02 better than the consensus estimate of $-0.18. […]
For its fourth fiscal quarter (ending June 30), Bio-Techne Corp (NASDAQ: TECH) has reported a -46% decline in E.P.S. from $0.48 a year ago to $0.26 in the current quarter. This result fell short of […]
Supernus Pharmaceuticals Inc (NASDAQ: SUPN) stock enjoyed a major increase of 14.5% on 8/7/24. The shares closed at $31.92. Moreover, trading volume in this advance was exceptionally high at 299% of normal. The stock has […]
Mastech Digital Inc (NYSEAMERICAN: MHH) has reported E.P.S. of $0.12 for its second fiscal quarter (ending June 30) versus $-0.19 for the same period a year ago. This performance was $0.05 better than the consensus […]
Zimmer Biomet Holdings Inc (NYSE: ZBH) has reported E.P.S. of $1.18 for its second fiscal quarter (ending June 30) versus $1.00 for the same period a year ago — an increase of 18%. Relative to […]
For its second fiscal quarter (ending June 30), Ziff Davis Inc (NASDAQ: ZD) has reported a 125% increase in E.P.S. from $0.36 a year ago to $0.81 in the current quarter. However, this performance was […]
TripAdvisor Inc (NASDAQ: TRIP) stock closed at $13.61 on 8/7/24 after a major decline of -16.6%. Moreover, exceptionally high trading volume at 453% of normal accompanied the decline. The stock has declined -24.5% during the […]
Monster Beverage Corp (NASDAQ: MNST) has reported earnings for its second fiscal quarter (ending June 30) of $0.41 versus $0.40 for the same period a year ago — an increase of 2%. However, this result […]
For its second fiscal quarter (ending June 30), Kratos Defense & Security Soluti (NASDAQ: KTOS) has reported E.P.S. of $0.05 compared to $-0.02 a year ago. This result fell short of the consensus estimate of […]
For its second fiscal quarter (ending June 30), CoreCivic Inc (NYSE: CXW) has reported a 31% increase in E.P.S. from $0.13 a year ago to $0.17 in the current quarter. This performance was $0.03 better […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research